The term apheresis (pronunciation: /əfərɪsɪs/) originates from the Greek word ἀφαίρεσις and from the Latin word aphaeresis, meaning “elimination”, “removal”, ”taking away”. In medicine, any process that results in “removal” of cells, molecules, components, toxins from the blood or from an organism may be considered apheresis.
Broadly speaking, most medical procedures may be considered apheresis procedures. Since time immemorial, witch doctors, shamans, alchemists and later modern-day chemists, pharmacists, doctors have tried to more or less selectively remove “spirits”, “tempers”, “poisons” and later bacteria, viruses, cells, molecules from the human body.
In particular, dialysis (both extracorporeal and peritoneal), blood component separation, gas removal, and filtration and adsorption therapies in general are apheresis processes. It is such a hugely vast and articulated world that taking a methodical approach is quite daunting.
Beyond the world of productive apheresis, whoever engages in therapeutic apheresis is faced with such a horde of molecules that can be removed, techniques that can be used, diseases that can be tackled that they get intimidated.
And many just “pull back”. The industries often come up with some more sophisticated apheresis therapies, but generally just offer techniques, rarely therapies, not worrying too much about the results and not tackling the issue holistically and methodically.
Clinicians that use “apheresis” approaches often need to base themselves on their own conviction as these “techniques” many a time run into the evidence-based hurdle. Clinical evidence in pharmaceutics is also often the child of the operating and financial capacity of the big companies in the sector and is, as understood today, related to the fact that apheresis therapies struggle to obtain large numbers with consequent foundering of the efforts of those who would like to give breath to this therapeutic approach.
AFERETICA IS COMMITTED TO GIVING THERAPEUTIC APHERESIS THE RANK IT DESERVES.
Aferetica was born small but with the ambition to contribute to changing this situation.
We would like to be the catalyst for the creation of a network of clinicians, academicians, researchers, industrialists and institutions capable of creating, validating and using apheresis therapies in clinical practice as well as launch their use in new and unexplored clinical areas.
Therapies made not only of products but also knowledge, “know-how”, therapeutic protocols, clinical research, comparison – in a nutshell, a specific culture.
What drives us is the idea that not only economic resources move the world but also and especially ideas, enthusiasm, and wanting to do.